Category

Science & Research

← All posts
Conditions

Ketamine for Anxiety Disorders: What the Research Shows

Ketamine anxiety treatment has shown rapid, short-lived reductions in symptoms of generalized and social anxiety disorder across several small controlled trials, often within hours of a...

July 28, 2026 · 8 min
Conditions

Ketamine for Treatment-Resistant Depression: The Fastest-Acting Antidepressant

Ketamine for treatment-resistant depression can reduce symptoms within hours rather than the four to six weeks standard antidepressants typically require, and in a single large controlled...

July 27, 2026 · 8 min
Psilocybin

Psilocybin Therapy Guide: A Complete Guide to Therapeutic Use

Psilocybin is the active compound in certain mushrooms, and in a therapeutic setting it is used in one or two carefully prepared sessions alongside professional psychological...

July 7, 2026 · 9 min
Executive

Psychedelic Therapy Screening: Are You a Candidate?

A psychedelic therapy screening assessment is the structured clinical process that determines whether you are a suitable candidate for psilocybin or similar modalities. For high-performing individuals,...

May 27, 2026 · 8 min
Legal / Policy / Geo-Legal

MDMA Therapy 2026 Update: Where Things Stand After the FDA Rejection

The FDA rejected Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD in August 2024, and as of mid-2026 that decision stands. MDMA remains a Schedule I...

May 27, 2026 · 10 min
Executive

Psychedelic Therapy FAQ: Honest Answers for the Educated Seeker

This psychedelic therapy FAQ compiles the most common and most important questions from people seriously considering psilocybin or other psychedelic-assisted approaches. The answers here are grounded...

May 26, 2026 · 10 min
Preparation / Integration

Six Months After Psilocybin: What the Research Shows About Long-Term Outcomes

Research from Johns Hopkins, NYU, and Imperial College London shows that psilocybin long term effects on depression and anxiety can persist well beyond the session itself,...

May 24, 2026 · 9 min
Executive

The JOM11 Framework: Concierge Psychedelic Therapy for Executives

The JOM11 psychedelic executive program is JourneyOM’s structured, concierge-level pathway for senior leaders who want to address burnout, cognitive rigidity, or performance plateaus through professionally supported...

May 23, 2026 · 9 min
Science & Research

Microdosing Protocols in 2026: Fadiman, Stamets, and the Clinical Data

The two most widely followed microdosing protocols are the Fadiman protocol (one day on, two days off) and the Stamets Stack (four or five days on,...

May 21, 2026 · 9 min
Executive

Psilocybin Grief Therapy: What High-Functioning People Often Carry

Psilocybin grief therapy is an emerging, clinically-studied approach for individuals whose grief has persisted well beyond the expected acute phase. For high-functioning professionals who have maintained...

May 20, 2026 · 9 min

Ready to take the next step?

Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.